Seo-Yong Cho
Chief Executive Officer at NDFOS CO., LTD.
Profile
Seo-Yong Cho is currently the Chief Executive Officer & Director at NDFOS Co., Ltd., Director at Neotx Holdings Ltd., and Director at CURE BIO Co., Ltd.
He has an educational background from Seoul National University, where he completed his undergraduate and doctorate degrees.
Seo-Yong Cho active positions
| Companies | Position | Start |
|---|---|---|
| NDFOS CO., LTD. | Chief Executive Officer | - |
CURE BIO Co., Ltd.
 CURE BIO Co., Ltd. BiotechnologyHealth Technology CURE BIO Co., Ltd. ENGAGES in the research and development of therapeutic and diagnostic products through the use of aminoacyl tRNA synthetase. The company was founded in 2002 and is headquartered in Seoul, South Korea. | Director/Board Member | - |
Neotx Holdings Ltd.
 Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | Director/Board Member | - |
Training of Seo-Yong Cho
| Seoul National University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NDFOS CO., LTD. | Process Industries |
| Private companies | 2 |
|---|---|
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | Health Technology |
CURE BIO Co., Ltd.
CURE BIO Co., Ltd. BiotechnologyHealth Technology CURE BIO Co., Ltd. ENGAGES in the research and development of therapeutic and diagnostic products through the use of aminoacyl tRNA synthetase. The company was founded in 2002 and is headquartered in Seoul, South Korea. | Health Technology |
- Stock Market
- Insiders
- Seo-Yong Cho